Grapevine, Texas — According to state and local economic development sources NextMed plans to invest $1,400,000.00 to build out 7,798 square feet of new space in Grapevine. The company plans to occupy the new space at 1601 LANCASTER DRIVE in Grapevine, on or about August 1, 2022. According to the company website NextMed is the most advanced, data-driven lithotripsy service on the market and we have invested tens of millions of dollars to create the optimal tools and protocols to drive the best outcomes in the industry. We are the only lithotripsy provider to earn the highest level of HFAP accreditation. We hold ourselves to the highest standards through rigorous training and technological advancements to ensure the best possible outcomes for physicians and patients. NextMed is committed to the vision of Revolutionizing the Delivery of Healthcare by designing and implementing service models that are measurable and deliver superior outcomes for patients, practitioners and facilities. Many common views of healthcare delivery and compensation are based in the belief that all delivery models are equal and that success is determined by the lowest price. NextMed knows that the greatest returns are achieved with the very best outcomes and the lowest over-all cost – not to be confused with price. To this end, NextMed is deeply respectful of the need for payers and providers to increase their returns, and NextMed knows that this is best accomplished through the delivery of superior medical services that provide the best patient outcomes. To help demonstrate this commitment, NextMed became the first company to achieve Joint Commission accreditation as a Mobile Lithotripsy and Laser Services provider.

To learn more about NextMed, visit http://www.nextmed.net/

Company Contact:
Chris Gleason, President
800-852-5695

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved